These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1297605)

  • 1. Sex differences in plasma cholesterol and apolipoprotein B levels in non-obese type 2 diabetic subjects.
    Ikeda T; Terasawa H; Ishimura M; Ochi H; Ohtani D; Fujiyama K; Hoshino T; Tanaka Y; Mashiba H
    Diabete Metab; 1992; 18(6):465-7. PubMed ID: 1297605
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum lipids and apolipoproteins AI, B100, CI and CII in noninsulin-dependent diabetics].
    Liu BW; Liang JS; Fu MD
    Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):627-9, 653-4. PubMed ID: 3147855
    [No Abstract]   [Full Text] [Related]  

  • 3. Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies.
    Boemi M; James RW; Romagnoli F; Gerber P; Pometta D; Fumelli P
    Diabetologia; 1993 Mar; 36(3):229-33. PubMed ID: 8462771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum apolipoproteins in heterozygous familial hypercholesterolemia.
    Kajinami K; Mabuchi H; Koizumi J; Takeda R
    Clin Chim Acta; 1992 Oct; 211(1-2):93-9. PubMed ID: 1468157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid and lipoprotein patterns in type 2 non-obese diabetic patients. Do Lp(a) levels decrease with improved glycemic control in these patients?
    Alagözlü H; Gültekin F; Candan F
    Nutr Metab Cardiovasc Dis; 2000 Aug; 10(4):204-8. PubMed ID: 11079258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
    Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
    Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes.
    Hu A; Luo Y; Li T; Guo X; Ding X; Zhu X; Wang X; Tang S
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):957-62. PubMed ID: 22327732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group.
    Kazumi T; Yoshino G; Ishida Y; Iwatani I; Morita S; Tateiwa M; Kasuga M
    Diabetes Res Clin Pract; 1995 Jan; 27(1):61-8. PubMed ID: 7781495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid metabolism in Norplant-2 users--a two-year follow-up study. Total cholesterol, triglycerides, lipoproteins and apolipoproteins.
    Rabe T; Thuro HC; Goebel K; Borchardt C; Grunwald K; Runnebaum B
    Contraception; 1992 Jan; 45(1):21-37. PubMed ID: 1591919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
    Buring JE; O'Connor GT; Goldhaber SZ; Rosner B; Herbert PN; Blum CB; Breslow JL; Hennekens CH
    Circulation; 1992 Jan; 85(1):22-9. PubMed ID: 1728453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic control affects plasma lipid and apolipoprotein levels in women, but not in men, with IDDM.
    Benzi L; Marchetti P; Giampietro O; Miccoli R; Pecori N; Sanna G; Caricato F; Giovannitti MG; Ciccarone AM; Navalesi R
    Acta Diabetol Lat; 1988; 25(2):149-54. PubMed ID: 3223190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood sugar and lipid metabolism parameters in diabetic retinopathy].
    Schmut O; Fellinger C; Hofmann H
    Klin Monbl Augenheilkd; 1985 May; 186(5):347-50. PubMed ID: 3927059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus.
    Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A
    Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes.
    Valabhji J; Donovan J; McColl AJ; Schachter M; Richmond W; Elkeles RS
    Diabet Med; 2002 May; 19(5):424-8. PubMed ID: 12027932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of insulin on cholesterol synthesis in type II diabetes patients.
    Scoppola A; Testa G; Frontoni S; Maddaloni E; Gambardella S; Menzinger G; Lala A
    Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes.
    Wägner AM; Pérez A; Sánchez-Quesada JL; Ordóñez-Llanos J
    Diabetes Care; 2005 Jul; 28(7):1798-800. PubMed ID: 15983340
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoprotein metabolism in postmenopausal and oophorectomized women.
    Wakatsuki A; Sagara Y
    Obstet Gynecol; 1995 Apr; 85(4):523-8. PubMed ID: 7898827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.